1 March 2016 - the March 2016 issue of the Schedule sees the listing of a number of new medicines/combination products/formulations for the treatment of patients with respiratory disease (asthma and chronic obstructive pulmonary disease). Some of these medicines/combination products have not been considered by PTAC, let alone recommended by PTAC.  Insofar as the MAESTrO database only captures the outcomes and listings of technologies that have a PTAC outcome; some of these new listings are not in the database.

For more details, go to: http://www.pharmac.govt.nz/2016/02/18/SU.pdf